Science Potential: BiomimicryFrom Investor Presentation back in 2015 transformed into text:
Sirona's Glycoprotein program
- - Cosmetic Active Ingredients
- - - - Anti-aging
- - - - Protection & Regeration
- - - - - - Healing / wound care
- - - - - - Hypothermic protection
- - - - - - Sunscreen
- - - - - - Post-sunburn / radiotherapy
- - Adjuvants for biological material preservation
- - - - Cells
- - - - - - Stem cells
- - - - - - Islet cells
- - - - - - Platelets
- - - - - - Red blood cells
- - - - - - Adipocytes
- - - - Tissues
- - - - - - Skin explants
- - - - - - RHE
- - - - - - Cornea
- - - - Organs
- - - - - - Transplant
- - - - - - Renal Reperfusion
- - - - Living organisms
- - - - - - Vaccines
All we need now is that the management impress us with science transformation into very profitable deals. Where is the SGLT2 deals? Anyone?